Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
> genetic data starts being resold Or hacked.
GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
11–20 of 228 posts
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#12Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#13Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
“Based on your genetic profile you’re 27% more likely to develop ________, talk to your doctor about how GSK’s _________ can help”
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#14Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#15Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Both of my parents have used 23andMe. In that case although I've never consented 23andMe knows quite a bit about my genetic profile. I wonder if this sort of "inferred" data is going to be traded.
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#16Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Imagine the possibilities of direct to consumer targeted marketing: “ Based on your genetic profile you’re 27% more likely to develop ________, talk to your doctor about how GSK’s _________ can help ”
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#17Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#18Externally, they're a family company helping you understand your family history and equipping you to anticipate health problems so you can prepare for them.
Internally, in presentations to venture capitalists and in job interviews with engineers like me, the picture is quite different. They're building a genetic database and plotting world domination from a thousand different angles that most people could never have even imagined.
This stuff is straight out of a dystopian sci-fi novel.
23andMe is very similar to Google in this regard. We never imagined Google would have so much access to data, we never thought of the consequences. Now Google wields an absolutely unfathomable level of power over everyone in the world, and all anybody can really do is trust them not to abuse it.
And also trust that all future generations and governments that inherit Google will never abuse it.
23andMe is one of those companies, but we aren't just talking about your searches and communications, we're talking about genetics and humanity and life itself on a very fundamental level.
The ethical and moral dilemmas haven't been brought to light yet in a meaningful way, but it's inevitable, and they're some seriously next-level moral dilemmas. Even for Silicon Valley.
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#19Make no mistake about what is happening here. GSK is buying access to all of the genetic data that 23andMe has. This is why I am wary to use any 23andMe type of service. "The partners plan to use 23andMe’s data to jointly discover drug targets." They will claim all kinds of protections of course, but it is only a matter of time until genetic data starts being resold.
Is there a way for them to use the data "to jointly discover drug targets" in aggregate without names/identifiers?
Re: GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
#20Earlier quoted context omitted.
Imagine the possibilities of direct to consumer targeted marketing: “ Based on your genetic profile you’re 27% more likely to develop ________, talk to your doctor about how GSK’s _________ can help ”
Why is that a bad thing? Wouldn't want it popping up while I'm looking for dinner recipes, but it's a hell of a lot more useful than shoe ads. It needs to be deeply regulated -- but most ads indicating health benefits already are .
People bang on about early intervention, and it's useful for some stuff, but for a lot of stuff there's no evidence of a reduction in all cause mortality.